메뉴 건너뛰기




Volumn 81, Issue 20, 2013, Pages 1728-1729

Amyloid and neurodegeneration: Converging and diverging paths

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

EID: 84888270494     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000435568.38352.2e     Document Type: Editorial
Times cited : (6)

References (14)
  • 1
    • 10744232413 scopus 로고    scopus 로고
    • Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B
    • Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B. Ann Neurol 2004;55:306-319.
    • (2004) Ann Neurol , vol.55 , pp. 306-319
    • Klunk, W.E.1    Engler, H.2    Nordberg, A.3
  • 2
    • 0032989712 scopus 로고    scopus 로고
    • Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
    • Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-368.
    • (1999) Ann Neurol , vol.45 , pp. 358-368
    • Price, J.L.1    Morris, J.C.2
  • 3
    • 79956098248 scopus 로고    scopus 로고
    • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    • Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
    • (2011) Alzheimers Dement , vol.7 , pp. 280-292
    • Sperling, R.A.1    Aisen, P.S.2    Beckett, L.A.3
  • 4
    • 79956084514 scopus 로고    scopus 로고
    • The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    • Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7: 270-279.
    • (2011) Alzheimers Dement , vol.7 , pp. 270-279
    • Albert, M.S.1    Dekosky, S.T.2    Dickson, D.3
  • 5
    • 84881476667 scopus 로고    scopus 로고
    • The A4 trial: Anti-amyloid treatment of asymptomatic Alzheimer's disease
    • Sperling R, DonohueM, Aisen P. The A4 trial: anti-amyloid treatment of asymptomatic Alzheimer's disease. Alzheimers Dement 2012;8:P425-P426.
    • (2012) Alzheimers Dement , vol.8
    • Sperling, R.1    Donohue, M.2    Aisen, P.3
  • 6
    • 84888228877 scopus 로고    scopus 로고
    • Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity
    • Jack CR Jr, Wiste HJ, Weigand SD, et al. Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology 2013;81:1732-1740.
    • (2013) Neurology , vol.81 , pp. 1732-1740
    • Jack Jr., C.R.1    Wiste, H.J.2    Weigand, S.D.3
  • 7
    • 77649314191 scopus 로고    scopus 로고
    • APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
    • Morris JC, Roe CM, Xiong C, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010;67:122-131.
    • (2010) Ann Neurol , vol.67 , pp. 122-131
    • Morris, J.C.1    Roe, C.M.2    Xiong, C.3
  • 8
    • 77954033257 scopus 로고    scopus 로고
    • Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
    • Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010;31: 1275-1283.
    • (2010) Neurobiol Aging , vol.31 , pp. 1275-1283
    • Rowe, C.C.1    Ellis, K.A.2    Rimajova, M.3
  • 9
    • 55449111089 scopus 로고    scopus 로고
    • Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence
    • Garibotto V, Borroni B, Kalbe E, et al. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology 2008;71:1342-1349.
    • (2008) Neurology , vol.71 , pp. 1342-1349
    • Garibotto, V.1    Borroni, B.2    Kalbe, E.3
  • 10
    • 84895642075 scopus 로고    scopus 로고
    • Cholinergic activity correlates with reserve proxies in Alzheimer's disease
    • Garibotto V, Tettamanti M, Marcone A, et al. Cholinergic activity correlates with reserve proxies in Alzheimer's disease. Neurobiol Aging 2013;34:e2613-e2698.
    • (2013) Neurobiol Aging , vol.34
    • Garibotto, V.1    Tettamanti, M.2    Marcone, A.3
  • 11
    • 84859406520 scopus 로고    scopus 로고
    • Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: Head-to-head comparison
    • Caroli A, Prestia A, Chen K, et al. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med 2012;53:592-600.
    • (2012) J Nucl Med , vol.53 , pp. 592-600
    • Caroli, A.1    Prestia, A.2    Chen, K.3
  • 12
    • 84862767786 scopus 로고    scopus 로고
    • An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
    • Jack CR Jr, Knopman DS, Weigand SD, et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 2012;71:765-775.
    • (2012) Ann Neurol , vol.71 , pp. 765-775
    • Jack Jr., C.R.1    Knopman, D.S.2    Weigand, S.D.3
  • 13
    • 84858019144 scopus 로고    scopus 로고
    • The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging
    • Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 2012;78:342-351.
    • (2012) Neurology , vol.78 , pp. 342-351
    • Roberts, R.O.1    Geda, Y.E.2    Knopman, D.S.3
  • 14
    • 80955137862 scopus 로고    scopus 로고
    • Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia
    • Klunk WE. Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging 2011;32:S20-S36.
    • (2011) Neurobiol Aging , vol.32
    • Klunk, W.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.